Table 1 List of the marmosets that were used in this study inoculated with clinically isolated dengue virus
Type of infection | Primary infection | Secondary infection | Tertiary infection | Intervals between DENV infection | Marmosets ID |
|---|---|---|---|---|---|
Serotype (Genotype) | Serotype (Genotype) | Serotype (Genotype) | |||
Primary infection | |||||
 Group 1 | D1 (GI) |  |  |  | M1, M2 |
 Group 2 | D1 (GII) |  |  |  | M3–1, M4–1, M5–1, M6, |
 Group 3 | D2 (Cosmopolitan) |  |  |  | M7–1, M8–1, M9–1, M10, M11, M12, M13, M14 |
 Group 4 | D2 (Asian I) |  |  |  | M15–1, M16–1, M17–1, M18, M19, M20 |
 Group 5 | D2 (Asian/American) |  |  |  | M21, M22, M23 |
Secondary infection | |||||
 Homologous genotype | |||||
  Group 6 | D2 (Cosmopolitan) | D2 (Cosmopolitan) |  | 6 months | M24, M25 |
 Heterologous genotype | |||||
  Group 7 | D2 (Asian I) | D2 (Cosmopolitan) |  | 6 months | M15–2, M16–2, M17–2, M26 |
 Homologous serotype | |||||
  Group 8 | D1 (GII) | D1 (GI) |  | 7 months | M3–2, M4–2, M5–2 |
 Heterologous serotype | |||||
  Group 9 | D2 (Cosmopolitan) | D1 (GI) |  | 12 months | M7–2, M8–2, M9–2 |
Tertiary infection | |||||
 Group 10 | D2 (Asian I) | D2 (Cosmopolitan) | D1 (GI) | 12 months | M15–3, M16–3, M17–3 |
Primary infection with monovalent live-attenuated DEN vaccine candidate | |||||
 Group 11 | D1 16007 PDK-13 (GII) |  |  |  | V1–1, V2–1, V3–1, V4–1 |
 Group 12 | D2 16881 PDK-53 (Asian I) |  |  |  | V5–1, V6–1 |
Secondary infection | |||||
 Group 13 | D1 16007 PDK-13 (GII) | D1 (GI) |  | 7 months | V1–2, V2–2, V3–2, V4–2 |
 Group 14 | D2 16881 PDK-53 (Asian I) | D2 (Cosmopolitan) |  | 6 months | V5–2, V6–2, V7–1, V8 |
Tertiary infection | |||||
 Group 15 | D2 16881 PDK-53 (Asian I) | D2 (Cosmopolitan) | D1 (GI) | 12 months | V5–3, V7–2 |